Oxyrane (AgeTech UK) Biomed
Central nervous system diseases, enzyme replacement therapies, lysosomal storage diseases. Oxyrane develops enhanced enzyme replacement therapies (ERTs) for the treatment of lysosomal storage diseases, with a focus on the diseases of the central nervous system.
Technology:
AgeTech Companies
Industry:
UK AgeTech 2020
Headquarters:
United Kingdom
Founded Date:
N/A
Employees Number:
N/A
Funding Status:
N/A
Register and Claim Ownership